Study reveals how light-activated macrophages increase their appetite for cancer cells

With hopes of de­thron­ing Re­gen­eron’s block­buster eye drug fran­chise Eylea, Roche on Thurs­day an­nounced the FDA has ex­pand­ed the la­bel of its own block­buster eye

The still-mysterious immunologic syndrome known as VEXAS seems to include heightened risk of infection, said researchers who warned that their findings suggest that the condition